Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07BXE
|
||||
| Former ID |
DIB005578
|
||||
| Drug Name |
Daniquidone
|
||||
| Synonyms |
Batracylin
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Lymphoma [ICD9: 202.8, 208.9; ICD10:C81-C86] | Phase 1 | [521991] | ||
| Company |
National Cancer Institute
|
||||
| Formula |
C15H11N3O
|
||||
| Canonical SMILES |
C12=Nc3c(CN1C(=O)c1c2cccc1)cc(cc3)N
|
||||
| CAS Number |
CAS 67199-66-0
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Toposisomerase-1 | Target Info | Modulator | ||
| DNA topoisomerase II | Target Info | Modulator | |||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| PANTHER Pathway | DNA replication | ||||
| Pathway Interaction Database | Caspase Cascade in Apoptosis | ||||
| WikiPathways | Integrated Pancreatic Cancer Pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.